Malernee James K. Jr. - Net Worth and Insider Trading

Malernee James K. Jr. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Malernee James K. Jr. owns 1 companies in total, including ClearPoint Neuro Inc (CLPT) .

Click here to see the complete history of Malernee James K. Jr.’s form 4 insider trades.

Insider Ownership Summary of Malernee James K. Jr.

Ticker Comapny Transaction Date Type of Owner
CLPT ClearPoint Neuro Inc 2012-04-13 director

Malernee James K. Jr. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Malernee James K. Jr. Ownership Network

Ownership Network List of Malernee James K. Jr.

No Data

Ownership Network Relation of Malernee James K. Jr.

Insider Network Chart

Malernee James K. Jr. Owned Company Details

What does ClearPoint Neuro Inc do?

Who are the key executives at ClearPoint Neuro Inc?

Malernee James K. Jr. is the director of ClearPoint Neuro Inc. Other key executives at ClearPoint Neuro Inc include Chief Operating Officer Mazin Sabra , director & CEO and President Joseph Michael Burnett , and GM & Biologics & Drug Delivery L. Jeremy Stigall .

ClearPoint Neuro Inc (CLPT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ClearPoint Neuro Inc (CLPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ClearPoint Neuro Inc (CLPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ClearPoint Neuro Inc (CLPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

ClearPoint Neuro Inc Insider Transactions

No Available Data

Malernee James K. Jr. Mailing Address

Above is the net worth, insider trading, and ownership report for Malernee James K. Jr.. You might contact Malernee James K. Jr. via mailing address: One Commerce Square, Suite 2550, Memphis Tn 38103.

Discussions on Malernee James K. Jr.

No discussions yet.